Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1982-07-02
1983-11-01
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
424101, A61K 3700, A61K 3514
Patent
active
044129904
ABSTRACT:
There is disclosed a pharmaceutical composition for therapeutic use comprising an immune globulin and fibronectin in amounts sufficient to produce an opsonic activity in the composition that is greater than the additive opsonic activity of the individual agents or in amounts sufficient to produce a phagocytosis of infectious agents greater than the additive effect from fibronectin and immune globulin alone.
REFERENCES:
Biol. Abstr. vol. 66, (1978), 526.
Biol. Abstr. vol. 69, (1980), 51789.
Budinger Miriam D.
Lundblad John L.
Schwartz Richard S.
Cutter Laboratories, Inc.
Leitereg Theodore J.
Phillips Delbert R.
LandOfFree
Composition having enhanced opsonic activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition having enhanced opsonic activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition having enhanced opsonic activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2168486